Japan Tob (OTCMKTS:JAPAY) Sees Unusually-High Trading Volume – Here’s Why

Japan Tob (OTCMKTS:JAPAY) shares saw strong trading volume on Tuesday. Approximately 122,851 shares were traded during trading, a decline of 1% from the previous session’s volume of 124,003 shares. The stock last traded at $23.21 and had previously closed at $22.91.

Wall Street Analyst Weigh In

Separately, BTIG Research started coverage on Japan Tob in a research note on Wednesday, July 22nd. They set a “buy” rating for the company. One equities research analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $17.00.

Japan Tob Stock Performance

The firm has a 50-day moving average of $21.91 and a two-hundred day moving average of $20.08. The company has a quick ratio of 1.45, a current ratio of 2.04 and a debt-to-equity ratio of 0.35. The company has a market capitalization of $81.93 billion, a PE ratio of 16.84, a PEG ratio of 1.52 and a beta of 0.28.

Japan Tob (OTCMKTS:JAPAY) last announced its quarterly earnings results on Thursday, July 30th. The company reported $0.41 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.33 by $0.08. The company had revenue of $6.67 billion during the quarter, compared to analyst estimates of $6.15 billion. Research analysts anticipate that Japan Tob will post 1.13 EPS for the current year.

Japan Tob Company Profile

Japan Tobacco Inc is a Japan-based company engaged primarily in the manufacture and sale of tobacco products. Its portfolio includes combustible cigarettes, heated tobacco products and other reduced-risk nicotine products marketed under brands such as Winston, MEVIUS, Camel and Ploom. The company serves consumers in Japan and international markets through its tobacco business.

In addition to tobacco, Japan Tobacco operates businesses in pharmaceuticals and processed foods. Its pharmaceutical activities focus on prescription medicines, while its food operations include products such as frozen foods, seasonings and processed food ingredients.